IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX) in a research report sent to investors on Monday. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Stock Up 1.7 %

Shares of IRIX stock opened at $1.80 on Monday. The stock has a fifty day moving average price of $1.64 and a 200 day moving average price of $1.96. The stock has a market cap of $29.95 million, a P/E ratio of -2.69 and a beta of 0.80. IRIDEX has a one year low of $1.27 and a one year high of $3.65. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.54 and a quick ratio of 0.85.

IRIDEX (NASDAQ:IRIX) last posted its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.12) EPS for the quarter. IRIDEX had a negative return on equity of 192.95% and a negative net margin of 22.79%. The company had revenue of $11.58 million for the quarter. During the same period in the previous year, the business earned ($0.11) EPS.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.